Found 59 matching trials
A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE PHASE4 The objectives of the study were:
1. To assess the safety and tolerability...
Show More Location
Allergy, Asthma and Immunology Associates
Learn More & Join Trial
A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema PHASE1 This is a Phase 1/2, single-arm, open-label, dose-escalation and dose-expan...
Show More Status
Active Not Recruiting
Location
AllerVie Clinical Research
Learn More & Join Trial
A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor PHASE1 A new formulation of Berinert (CSL830) is being investigated for the manage...
Show More Learn More & Join Trial
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients PHASE3 This is a double-blind, randomized-withdrawal, placebo-controlled study in ...
Show More Location
University of Alabama Hospital (at Birmingham)
Learn More & Join Trial
C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks PHASE3 The study objective was to determine the safety and efficacy of C1INH-nf fo...
Show More Location
Allergy and Immunology Associates
Learn More & Join Trial
A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration PHASE2 Hereditary angioedema ("HAE") is a disease characterized by recurrent tissu...
Show More Location
For information on sites, please contact Pharming Technologies
Learn More & Join Trial
A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection PHASE2 The purpose of this research study is to evaluate the safety, effect, and p...
Show More Location
ViroPharma Investigative Site
Learn More & Join Trial
A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema PHASE3 The aim of this study is to assess the long-term safety of C1-esterase inhi...
Show More Learn More & Join Trial
In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II PHASE3 Excessive inflammation is associated with tissue damage caused by over-acti...
Show More Location
Radboud University
Learn More & Join Trial
Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks PHASE3 This study is being conducted to confirm the efficacy, safety, and immunoge...
Show More Location
Allergy, Asthma & Immunology, Assoc, Ltd.
Learn More & Join Trial